Össur - Full Year Report 2010

                                              Announcement Össur hf. No. 01/2011
                                                      Reykjavik, 7 February 2011

EXCELLENT SALES GROWTH

Sales  - Sales growth  was excellent, 9% measured  in local currency with strong
contribution  from  both  bracing  and  supports  and  prosthetics.  Total sales
amounted  to USD 359 million compared to USD 331 million in 2009. Performance in
bracing and supports was strong, with sales gradually increasing during the year
resulting  in 12% growth measured  in local currency.  Sales of prosthetics were
good, growing 8% measured in local currency.

Profitability  - Össur continues to deliver  stable margins.  EBITDA amounted to
USD  74 million or 21% of sales and gross  profit amounted to USD 223 million or
62% of sales. Net profit amounted to USD 35 million and 10% of sales compared to
USD  23 million and 7% of sales in 2009. Increased profit is primarily driven by
sales growth.


Jon Sigurdsson, President & CEO, comments:

"Overall the results for 2010 are very satisfying. The product pipeline has been
strong and an important contributor to this year's success. In 2010 we have seen
exciting mechanical solutions, breakthrough bionic products like the PROPRIO
FOOT as well as new bracing and support products launched. Excellent sales
growth in prosthetics is supported by solid performance in both EMEA and
Americas. Success of the bracing and supports segment in Americas is very
positive and confirms our strength in this segment."

Highlights of the year:
  * Strong product pipeline - The product pipeline was very strong in 2010. A
    total of 22 new products were launched including the PROPRIO FOOT which is
    the second product in the Bionic Platform. Products such as Miami Lumbar and
    Rebound Walker which were launched during the year contribute to the growth
    in the bracing and supports segment.
  * Expanding sales platform in Americas - Extensive change in the sales
    structure and strategy in Americas in 2009 is returning good growth in
    2010. Investments in distribution channels and increasing the sales
    coverage, have yielded good results and combined with a strong product
    pipeline have resulted in the bracing and support segment in Americas
    growing above the market growth rate.

Guidance  2011 - Management estimates LCY organic sales growth for 2011 to be in
the range of 4-6%. EBITDA adjusted is estimated to be in the range of 20-21% for
the year.


Conference call tomorrow 8 February at 12:00 CET/ 11:00 GMT/ 6:00 EST

Tuesday  8 February  2011 Jón  Sigurðsson,  President  and  CEO,  and Hjörleifur
Pálsson,   CFO,  will  host  a  conference  call  for  investors,  analysts  and
shareholders presenting and discussing the results of the fourth quarter and the
full year results for 2010. The conference call will be conducted in English and
can be heard on Össur's website: www.ossur.com

To  participate  in  the  meeting  please  call  one  of the following telephone
numbers:
Europe: +44 (0)20 3043 2436 or +46 (0)8 505 598 53
The United States: +1 866 458 40 87
Iceland: 800 8660




Further information

Jon Sigurdsson, President & CEO    Tel: +354 515 1300

Hjorleifur Palsson, CFO            Tel: +354 515 1300

Sigurborg Arnarsdottir, IR Manager Tel: +354 664-1044


NOTE: This page only includes the highlights of the full year. For the full
press release please visit www.ossur.com/investors